Brief: Veracyte Inc Announces New Expanded Data At Chest Underscoring Percepta Nasal Swab Test’S Ability
11/10/2021 13:16
Oct 11 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE ANNOUNCES NEW EXPANDED DATA AT CHEST UNDERSCORING
PERCEPTA NASAL SWAB TEST’S ABILITY TO IMPROVE EARLY LUNG CANCER
ASSESSMENT
* VERACYTE INC - BEGUN MAKING PERCEPTA NASAL SWAB TEST
AVAILABLE
TO A LIMITED NUMBER OF CLINICAL SITES
Source text for Eikon: ID:nBw9zTj62a
Further company coverage: VCYT.O
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina